A plasmid-based reverse genetics system for influenza A virus.

AUTOR(ES)

Pleschka, S

RESUMO

A reverse genetics system for negative-strand RNA viruses was first successfully developed for influenza viruses. This technology involved the transfection of in vitro-reconstituted ribonucleoprotein (RNP) complexes into influenza virus-infected cells. We have now developed a method that allows intracellular reconstitution of RNP complexes from plasmid-based expression vectors. Expression of a viral RNA-like transcript is achieved from a plasmid containing a truncated human polymerase I (polI) promoter and a ribozyme sequence that generates the desired 3' end by autocatalytic cleavage. The polI-driven plasmid is cotransfected into human 293 cells with polII-responsive plasmids that express the viral PB1, PB2, PA, and NP proteins. This exclusively plasmid-driven system results in the efficient transcription and replication of the viral RNA-like reporter and allows the study of cis- and trans-acting signals involved in the transcription and replication of influenza virus RNAs. Using this system, we have also been able to rescue a synthetic neuraminidase gene into a recombinant influenza virus. This method represents a convenient alternative to the previously established RNP transfection system.

Documentos Relacionados

• Human cytomegalovirus plasmid-based amplicon vector system for gene therapy
• A novel, plasmid-based system for studying gene rearrangements in mammalian cells.
• A plasmid-based system for expressing small interfering RNA libraries in mammalian cells
• Preferential cleavage of plasmid-based R-loops and D-loops by Drosophila topoisomerase IIIβ
• Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice